Of importance, inhibition of CD39 led to p-AMPKlow, p-S6high, and p-AKThigh in NSCLC-interacted T cells (Fig. 3F), impairing the metabolic-rewiring function of human NSCLC. This evidence concerns the gene ENTPD1 and non-small cell lung carcinoma.